Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-10 ,pp. : 253-257

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Molecule of the Angiotensin II Receptor Blocker Class: Focus on Olmesartan Medoxomil

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 79-89

Adis International

Access to resources Recommend Favorite

Angiotensin II Receptor Blocker as an Inverse Agonist: A Current Perspective

By  

Current Hypertension Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 115-121

Bentham Science Publishers

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy Comprising Angiotensin II Receptor Blocker Plus Calcium Channel Blocker on Plasma Adiponectin Levels

By Inoue Yukiko   Kakuma Tatsuyuki   Nonaka Yoshisuke   Sumi Shunichiro   Okamura Keisuke   Kodama Sunao   Ando Chie   Niimura Hideya   Miyoshi Kei   Tsuchiya Yoshihiro   Yamanouchi Yoshio   Urata Hidenori  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite

What is the association of acute renal failure, angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker in a young patient?

By Yüksel Selçuk   Koçyiğit Ali   Uzun Ebru   Tepeli Emre   Özcan Vefa   Becerir Tülay  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 98-99

Oxford University Press

Access to resources Recommend Favorite